Loading organizations...
City of Hope operates as a prominent non-profit clinical research center, hospital, and graduate school, focused on cancer and diabetes. It integrates scientific discovery with comprehensive patient care, developing innovative treatments and conducting extensive biomedical research. This unified approach facilitates the translation of laboratory findings into direct clinical advancements, pushing the boundaries of medical science.
The institution's origins trace to 1913, when a compassionate group of volunteers established the Jewish Consumptive Relief Association (JCRA). Their foundational insight was the critical need for free, nonsectarian care for tuberculosis patients, initially delivered from two tents in Duarte, California. This collective humanitarian effort laid the groundwork for a century of advanced medical service and scientific inquiry.
City of Hope serves a diverse patient population affected by cancer and diabetes, offering specialized treatment and advanced care. Its overarching vision is to profoundly impact the future of medicine by accelerating the translation of scientific breakthroughs into life-saving patient benefits. The organization remains dedicated to advancing curative therapies and ensuring access to cutting-edge medical innovations for all individuals.
Key people at City of Hope.
Key people at City of Hope.
City of Hope has 1 tracked investment across 1 company. The latest tracked deal is $25.0M Series A in Reimagine Care in January 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2022 | Reimagine Care | $25.0M Series A | Santé Ventures, Lrvhealth, Martin Ventures | Alpha Venture Partners, CU Healthcare Innovation Fund, McKesson Ventures, Sable Investments |